ZENLISTIQ Trademark

Trademark Overview

On Friday, March 1, 2013, a trademark application was filed for ZENLISTIQ with the United States Patent and Trademark Office. The USPTO has given the ZENLISTIQ trademark a serial number of 85864152. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, September 25, 2013. This trademark is owned by Eli Lilly and Company. The ZENLISTIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants
zenlistiq

General Information

Serial Number85864152
Word MarkZENLISTIQ
Filing DateFriday, March 1, 2013
Status601 - ABANDONED - EXPRESS
Status DateWednesday, September 25, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 7, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Wednesday, September 25, 2013ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Wednesday, September 25, 2013ABANDONMENT - EXPRESS MAILED
Tuesday, September 24, 2013TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, June 13, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 13, 2013NON-FINAL ACTION E-MAILED
Thursday, June 13, 2013NON-FINAL ACTION WRITTEN
Thursday, June 13, 2013ASSIGNED TO EXAMINER
Thursday, March 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 5, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

zenlistiq disorders diseases preparations system pharmaceutical metabolic liver kidney inflammatory inflammation